Javaherian K, Langlois A J, McDanal C, Ross K L, Eckler L I, Jellis C L, Profy A T, Rusche J R, Bolognesi D P, Putney S D
Repligen Corporation, Cambridge, MA 02139.
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72. doi: 10.1073/pnas.86.17.6768.
The principal neutralizing determinant of human immunodeficiency virus type 1 (HIV-1) is located in the external envelope protein, gp120, and has previously been mapped to a 24-amino acid-long sequence (denoted RP135). We show here that deletion of this sequence renders the envelope unable to elicit neutralizing antibodies. In addition, using synthetic peptide fragments of RP135, we have mapped the neutralizing determinant to 8 amino acids and found that a peptide of this size elicits neutralizing antibodies. This sequence contains a central Gly-Pro-Gly that is generally conserved between different HIV-1 isolates and is flanked by amino acids that differ from isolate to isolate. Antibodies elicited by peptides from one isolate do not neutralize two different isolates, and a hybrid peptide, consisting of amino acid sequences from two isolates, elicits neutralizing antibodies to both isolates. By using a mixture of peptides of this domain or a mixture of such hybrid peptides the type-specificity of the neutralizing antibody response to this determinant can perhaps be overcome.
人类免疫缺陷病毒1型(HIV-1)的主要中和决定簇位于外膜蛋白gp120中,此前已定位到一段24个氨基酸长的序列(称为RP135)。我们在此表明,删除该序列会使包膜无法引发中和抗体。此外,利用RP135的合成肽片段,我们已将中和决定簇定位到8个氨基酸,并发现这种大小的肽能引发中和抗体。该序列包含一个位于中心的甘氨酸-脯氨酸-甘氨酸,在不同的HIV-1分离株之间通常是保守的,两侧是因分离株而异的氨基酸。来自一个分离株的肽引发的抗体不能中和两种不同的分离株,而由来自两种分离株的氨基酸序列组成的杂合肽能引发针对两种分离株的中和抗体。通过使用该结构域的肽混合物或这种杂合肽的混合物,或许可以克服针对该决定簇的中和抗体反应的型特异性。